S100B is a calcium-binding protein mainly concentrated in astrocytes in the nervous system.
Its levels in biological fluids are recognized as a reliable biomarker of active neural distress …

Background Coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 infection is
associated with disorders affecting the peripheral and the central nervous system. A high …

Introduction A blood-based biomarker (BBBM) test could help to better stratify patients with
traumatic brain injury (TBI), reduce unnecessary imaging, to detect and treat secondary …

Aim The current study aimed to investigate the neuroinflammatory hypothesis of depression
and the potential anti‐inflammatory effect of electroconvulsive therapy (ECT) in vivo, utilizing …

Blood‐based biomarkers are promising tools to complement clinical variables and imaging
findings in the diagnosis, monitoring and outcome prediction of traumatic brain injury (TBI) …

The pathophysiological mechanisms underlying severe cardiac dysfunction after
aneurysmal subarachnoid haemorrhage (aSAH) remain poorly understood. In the present …

Traumatic brain injury (TBI) is currently one of the leading causes of mortality and disability
worldwide. At present, no reliable inflammatory or specific molecular neurobiomarker exists …

Explosive blasts are associated with neurological consequences as a result of blast waves
impact on the brain. Yet, the neuropathologic and molecular consequences due to blast …

Objectives Serum glial fibrillary acidic protein (GFAP) is an emerging biomarker for
intracerebral diseases and is approved for clinical use in traumatic brain injury. GFAP is also …

We aimed to find out which are the most frequent complications for patients who suffer a
traumatic brain injury (TBI) and its relation with brain biomarker levels. We conducted a …